The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Alzheimer disease in the United States (2010–2050) estimated using the 2010 census
Open accessAbstract
OBJECTIVES: To provide updated estimates of Alzheimer disease (AD) dementia prevalence in the United States from 2010 through 2050. METHODS: Probabilities of AD dementia incidence were calculated from a longitudinal, population-based study including substantial numbers of both black and white participants. Incidence probabilities for single year of age, race, and level of education were calculated using weighted logistic regression and AD dementia diagnosis from 2,577 detailed clinical evaluations of 1,913 people obtained from stratified random samples of previously disease-free individuals in a population of 10,800. These were combined with US mortality, education, and new US Census Bureau estimates of current and future population to estimate current and future numbers of people with AD dementia in the United States. RESULTS: We estimated that in 2010, there were 4.7 million individuals aged 65 years or older with AD dementia (95% confidence interval [CI] = 4.0-5.5). Of these, 0.7 million (95% CI = 0.4-0.9) were between 65 and 74 years, 2.3 million were between 75 and 84 years (95% CI = 1.7-2.9), and 1.8 million were 85 years or older (95% CI = 1.4-2.2). The total number of people with AD dementia in 2050 is projected to be 13.8 million, with 7.0 million aged 85 years or older. CONCLUSION: The number of people in the United States with AD dementia will increase dramatically in the next 40 years unless preventive measures are developed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As the U.S. population ages, the number of people with Alzheimer’s disease and related dementias (ADRD) is rapidly increasing,1,2”
From Review of Artificial Intelligence for Clinical Use in Alzheimer's Disease and Related Dementias (2026) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Sex is an important factor that contributes to the clinical and biological heterogeneities in Alzheimer’s disease (AD)”
From Sex-specific DNA methylation differences in Alzheimer’s disease pathology (2021) · cites this paper as [2]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The aging of the baby-boom generation will significantly increase the number of people in the United States with Alzheimer's.70”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [70]
The cited source says what the claim attributes to it.
In the citing paper
“The aging of the population, including the baby‐boom generation, will significantly increase the number of people in the United States with Alzheimer's dementia.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [78]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Of all AD patients in the United States, around two-thirds are women [2].”
From Sex specific molecular networks and key drivers of Alzheimer’s disease (2023) · cites this paper as [2]
Experimental — accuracy not yet measured
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Almost two-thirds of AD patients in the U.S. are women [2]”
From Sex-specific DNA methylation differences in Alzheimer’s disease pathology (2021) · cites this paper as [2]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Statistical Analysis With Missing Data
Lahiff, M., Little, R. J. A., & Rubin, D. B. (1989) · Journal of the American Statistical Association · doi:10.2307/2289883 · Cited by 17,385
Statistical Analysis with Missing Data
Little, R. J. A., & Rubin, D. B. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781119013563 · Cited by 8,473
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168
Self-citationPrevalence of Dementia in the United States: The Aging, Demographics, and Memory Study
Plassman, B. L., Langa, K. M., Fisher, G. G., Heeringa, S. G., Weir, D. R., Ofstedal, M. B., Burke, J. R., Hurd, M. D., Potter, G. G., Rodgers, W. L., et al. (2007) · Neuroepidemiology · doi:10.1159/000109998 · Cited by 1,932
Brookmeyer, R., Gray, S. G., & Kawas, C. H. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,802
2005 American Community Survey 1-Year Estimates
(2016) · Cited by 1,241
Missed and Delayed Diagnosis of Dementia in Primary Care: Prevalence and Contributing Factors
Bradford, A., Kunik, M. E., Schulz, P., Williams, S. P., & Singh, H. (2009) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181a6bebc · Cited by 969
Glover, J. W. (2010) · Cited by 917
Age-specific incidence rates of Alzheimer’s disease: The Baltimore Longitudinal Study of Aging
Kawas, C., Gray, S., Brookmeyer, R., Fozard, J., & Zonderman, A. (2000) · Neurology · doi:10.1212/wnl.54.11.2072 · Cited by 472
Research works printed but not linked: 1
- Bienias JL Kott PS Evans DA. Applying the delete-a-group jacknife varience estimator to analyses of data from a complex longitudinal survey . Proceedings of the Annual Meeting of the American Statistical Association Section on Survey Research Methods. Alexandria: American Statistical Association; 2003:539–544.
Cited by
Sorted by citations
Items 301–400 of 1,012
Managing Behavioral and Psychological Symptoms of Dementia
Gerlach, L. B., & Kales, H. C. (2017) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2017.10.010 · Cited by 95
A Deep Learning approach for Diagnosis of Mild Cognitive Impairment Based on MRI Images
Gorji, H. T., & Kaabouch, N. (2019) · Brain Sciences · doi:10.3390/brainsci9090217 · Cited by 101
Indorewalla, K. K., O’Connor, M. K., Budson, A. E., Guess (DiTerlizzi), C., & Jackson, J. (2021) · Journal of Alzheimer’s Disease · doi:10.3233/jad-201081 · Cited by 93
The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer’s Disease
Sulistio, Y. A., & Heese, K. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-9063-4 · Cited by 93
Bilingualism and Cognitive Reserve: A Critical Overview and a Plea for Methodological Innovations
Calvo, N., García, A. M., Manoiloff, L. M. V., & Ibáñez, A. M. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00249 · Cited by 111
Wu, W., Lee, I., Spratt, H. M., Fang, X., & Bao, X. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200917 · Cited by 94
“6 million LOAD and approximately 200,000 EOAD [2, 3].”
Khan, M. A., Alam, Q., Haque, A., Ashafaq, M., Khan, M. J., Ashraf, G. M., & Ahmad, M. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180828100002 · Cited by 92
Yuan, C., Chen, H., Wang, Y., Schneider, J. A., Willett, W. C., & Morris, M. C. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa303 · Cited by 94
“Int J Geriatr Psychiatry 2015;30(2):111–29.”
Salivary cortisol, brain volumes, and cognition in community-dwelling elderly without dementia
Geerlings, M. I., Sigurdsson, S. O., Eiríksdóttir, G., Garcia, M. E., Harris, T. B., Gudnason, V. G., & Launer, L. J. (2015) · Neurology · doi:10.1212/wnl.0000000000001931 · Cited by 96
Wu, H., Zhou, Y., Wang, Y., Tong, L., Wang, F., Song, S., Xu, L., Liu, B., Yan, H., & Sun, Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.717192 · Cited by 90
Sex differences in the blood–brain barrier and neurodegenerative diseases
Weber, C. M., & Clyne, A. M. (2021) · APL Bioengineering · doi:10.1063/5.0035610 · Cited by 95
Dhana, K., Beck, T., Desai, P., Wilson, R. S., Evans, D. A., & Rajan, K. B. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13081 · Cited by 90
Self-citationBeltran, W. A., Cideciyan, A. V., Iwabe, S., Świder, M., Kosyk, M. S., McDaid, K. S., Martynyuk, I., Ying, G., Shaffer, J., Deng, W., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1509914112 · Cited by 94
Automatic diagnosis of mild cognitive impairment using electroencephalogram spectral features
Rabbani, H., Kashefpoor, M., & Barekatain, M. (2016) · Journal of Medical Signals & Sensors · doi:10.4103/2228-7477.175869 · Cited by 90
Shaughnessy, K. A., Hackney, K. J., Clark, B. C., Kraemer, W. J., Terbizan, D. J., Bailey, R. R., & McGrath, R. (2020) · Journal of Alzheimer’s Disease · doi:10.3233/jad-190856 · Cited by 90
Dubal, D. B. (2020) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64123-6.00018-7 · Cited by 92
Wong, H., Levenga, J., Cain, P., Rothermel, B. A., Klann, E., & Hoeffer, C. A. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1499-8 · Cited by 91
Blood Pressure and Cognitive Decline Over 8 Years in Middle-Aged and Older Black and White Americans
Levine, D. A., Galecki, A. T., Langa, K. M., Unverzagt, F. W., Kabeto, M. U., Giordani, B., Cushman, M., McClure, L. A., Safford, M. M., & Wadley, V. G. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12062 · Cited by 91
Guercio, B. J., Donovan, N. J., Munro, C. E., Aghjayan, S. L., Wigman, S. E., Locascio, J. J., Amariglio, R. E., Rentz, D. M., Johnson, K. A., Sperling, R. A., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150146 · Cited by 98
Canevelli, M., Quarata, F., Remiddi, F., Lucchini, F., Lacorte, E., Vanacore, N., Bruno, G., & Cesari, M. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.11.035 · Cited by 97
Snowden, M. B., Steinman, L. E., Bryant, L. L., Cherrier, M. M., Greenlund, K. J., Leith, K. H., Levy, C. R., Logsdon, R. G., Copeland, C., Vogel, M. T., et al. (2017) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4652 · Cited by 97
Economic analysis of opportunities to accelerate Alzheimer's disease research and development
Scott, T. J., O’Connor, A. C., Link, A. N., & Beaulieu, T. J. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12417 · Cited by 91
Big Data and the Future of Radiology Informatics
Kansagra, A. P., Yu, J. J., Chatterjee, A. R., Lenchik, L., Chow, D. S., Prater, A. B., Yeh, J., Doshi, A. M., Hawkins, C. M., Heilbrun, M. E., et al. (2015) · Academic Radiology · doi:10.1016/j.acra.2015.10.004 · Cited by 88
Neural stem cell therapy for neurovascular injury in Alzheimer's disease
Boese, A. C., Hamblin, M. H., & Lee, J. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113112 · Cited by 89
Bioinformatics methods in drug repurposing for Alzheimer’s disease
Siavelis, J. C., Bourdakou, M. M., Athanasiadis, E. I., Spyrou, G. M., & Nikita, K. S. (2015) · Briefings in Bioinformatics · doi:10.1093/bib/bbv048 · Cited by 85
Adverse outcomes of long-term use of proton pump inhibitors: a systematic review and meta-analysis
Islam, M. M., Poly, T. N., Walther, B. A., Dubey, N. K., Anggraini Ningrum, D. N., Shabbir, S.-A., & (Jack) Li, Y.-C. (2018) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001198 · Cited by 88
Rabey, J. M., & Dobronevsky, E. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1606-6 · Cited by 86
Burnout After Patient Death: Challenges for Direct Care Workers
Boerner, K., Gleason, H. P., & Jopp, D. S. (2017) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2017.06.006 · Cited by 86
Dietary pattern in relation to the risk of Alzheimer’s disease: a systematic review
Samadi, M., Moradi, S., Moradinazar, M., Mostafai, R., & Pasdar, Y. (2019) · Neurological Sciences · doi:10.1007/s10072-019-03976-3 · Cited by 89
Sayed, A., Bahbah, E. I., Kamel, S., Barreto, G. E., Ashraf, G. M., & Elfil, M. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577398 · Cited by 88
Fritze, T., Teipel, S. J., Óvári, A., Kilimann, I., Witt, G., & Doblhammer, G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156876 · Cited by 93
Kerdiles, O., Layé, S., & Calon, F. (2017) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2017.09.003 · Cited by 87
Dementia, Decision Making, and Capacity
Darby, R. R., & Dickerson, B. C. (2017) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000163 · Cited by 85
Li, H., Wang, Z., Fu, Z., Yan, M., Wu, N., Wu, H., & Yin, P. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-020533 · Cited by 87
The Public Health Road Map to Respond to the Growing Dementia Crisis
Olivari, B. S., French, M. E., & McGuire, L. C. (2020) · Innovation in Aging · doi:10.1093/geroni/igz043 · Cited by 84
Precision Nutrition for Alzheimer’s Prevention in ApoE4 Carriers
Norwitz, N. G., Saif, N., Ariza, I. E., & Isaacson, R. (2021) · Nutrients · doi:10.3390/nu13041362 · Cited by 92
“8 million by mid-century [2], imposing an unsustainable economic toll and an unimaginable human burden.”
BackgroundPotentially Unsafe Activities and Living Conditions of Older Adults with Dementia
Amjad, H., Roth, D. L., Samus, Q. M., Yaşar, S., & Wolff, J. L. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14164 · Cited by 84
Kazim, S. F., Blanchard, J., Dai, C., Tung, Y. C., LaFerla, F. M., Iqbal, I.-G., & Iqbal, K. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.07.001 · Cited by 87
Human aging and disease: Lessons from age-related macular degeneration
Luu, J. C., & Palczewski, K. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1721033115 · Cited by 88
Auditory system dysfunction in Alzheimer disease and its prodromal states: A review
Swords, G. M., Nguyen, L. T., Mudar, R. A., & Llano, D. A. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.04.001 · Cited by 89
Laks, J., Goren, A., Dueñas, H., Novick, D., & Kahle‐Wrobleski, K. (2015) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4309 · Cited by 95
β-Amyloid Prions and the Pathobiology of Alzheimer’s DiseasePreprint
Watts, J. C., & Prusiner, S. B. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a023507 · Cited by 90
Worries About Getting Alzheimer’s: Who’s Concerned?
Cutler, S. J. (2015) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317514568889 · Cited by 82
Breast cancer treatment and its effects on aging
Chang, L., Weiner, L. S., Hartman, S. J., Horvath, S., Jeste, D. V., Mischel, P. S., & Kado, D. M. (2018) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2018.07.010 · Cited by 84
Deardorff, W. J., Shobassy, A., & Grossberg, G. T. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.995639 · Cited by 83
High-Fat Diet-Induced Obesity Causes Sex-Specific Deficits in Adult Hippocampal Neurogenesis in Mice
Robison, L. S., Albert, N. M., Camargo, L. A., Anderson, B. M., Salinero, A. E., Riccio, D. A., Abi‐Ghanem, C., Gannon, O. J., & Zuloaga, K. L. (2019) · eNeuro · doi:10.1523/eneuro.0391-19.2019 · Cited by 90
Pathogenesis of age-related HIV neurodegeneration
Mackiewicz, M., Overk, C., Achim, C. L., & Masliah, E. (2019) · Journal of NeuroVirology · doi:10.1007/s13365-019-00728-z · Cited by 89
Morofuji, Y., & Nakagawa, S. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200224112534 · Cited by 86
Neuroprotective effects of leptin in the context of obesity and metabolic disorders
Davis, C., Mudd, J., & Hawkins, M. A. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.04.012 · Cited by 84
Potential Clinical Applications of PET/MR Imaging in Neurodegenerative Diseases
Drzezga, A. E., Barthel, H., Minoshima, S., & Sabri, O. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.129254 · Cited by 83
Cerebral microbleeds and risk of incident dementia: the Framingham Heart Study
Romero, J. R., Beiser, A., Himali, J. J., Shoamanesh, A., DeCarli, C. S., & Seshadri, S. S. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.02.018 · Cited by 84
Feng, M.-G., Liu, C.-F., Chen, L., Feng, W.-B., Liu, M., Hai, H., & Lu, J.-M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.043 · Cited by 80
Lee, J. (2018) · Journal of Gerontological Nursing · doi:10.3928/00989134-20180814-01 · Cited by 86
Dong, X. Z., Li, S., Chen, J., Li, Y., Wu, Y., & Zhang, D. (2020) · Nutrition Journal · doi:10.1186/s12937-020-00547-7 · Cited by 84
Jang, J., Kim, K., Yoon, J., & Park, C. B. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120165 · Cited by 80
Collaborators, G. 2. D. (2021) · Neuroepidemiology · doi:10.1159/000515393 · Cited by 83
Rombouts, F. J. R., Tresadern, G., Delgado, Ó., Martínez‐Lamenca, C., Gool, M. V., García-Molina, A., de Diego, S. A. A., Oehlrich, D., Prokopcová, H., Alonso, J. M., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01101 · Cited by 82
O’Brien, J. L., Jackson, J. W., Grodstein, F., Blacker, D., & Weuve, J. (2013) · Epidemiologic Reviews · doi:10.1093/epirev/mxt008 · Cited by 81
Self-citationMultiple Layers of CDK5R1 Regulation in Alzheimer’s Disease Implicate Long Non-Coding RNAs
Spreafico, M., Grillo, B., Rusconi, F., Battaglioli, E., & Venturin, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072022 · Cited by 79
Model-Based Projection of Dementia Prevalence in China and Worldwide: 2020–2050
Li, F., Qin, W., Zhu, M., & Jia, J. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210493 · Cited by 84
“Some studies set one value for all age groups [31, 33, 34]; however, in our principal scenario, we used three dif-ferentvaluesfordifferentagegroupsaccordingtoonestudyandadjustedfortheactualChinesecondition [32].”
Weng, X., Tan, Y., Fei, Q., Yao, H., Fu, Y., Wu, X., Zeng, H., Yang, Z., Zeng, Z., Liang, H., et al. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.154362 · Cited by 80
Immunosenescence of Natural Killer Cells, Inflammation, and Alzheimer’s Disease
Solana, C., Tarazona, R., & Solana, R. (2018) · International Journal of Alzheimer s Disease · doi:10.1155/2018/3128758 · Cited by 79
Brain arterial aging and its relationship to Alzheimer dementia
Gutierrez, J., Honig, L. S., Elkind, M. S. V., Mohr, J. P., Goldman, J. E., Dwork, A. J., Morgello, S., & Marshall, R. S. (2016) · Neurology · doi:10.1212/wnl.0000000000002590 · Cited by 77
Relationship Between Obesity, Alzheimer’s Disease, and Parkinson’s Disease: an Astrocentric View
Martín-Jiménez, C., Gaitán-Vaca, D. M., Echeverría, V., González, J., & Barreto, G. E. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0193-8 · Cited by 80
Powell, R. D., Abbott, A. R. N., Nelson, L. A., & Bertke, A. S. (2020) · Journal of Virology · doi:10.1128/jvi.01874-19 · Cited by 79
Wang, H., Fu, J., Xu, X., Yang, Z. R., & Zhang, T. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab142 · Cited by 78
Diagnostic Assessment and Management of Dysphagia in Patients with Alzheimer’s Disease
Boccardi, V., Ruggiero, C., Patriti, A., & Marano, L. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150931 · Cited by 85
Pistollato, F., Ohayon, E. L., Lam, A., Langley, G. R., Novak, T. J., Pamies, D., Perry, G. L., Trushina, E. V., Williams, R. S. B., Roher, A. E., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9175 · Cited by 82
APOE4 confers transcriptomic and functional alterations to primary mouse microglia
Machlovi, S. I., Neuner, S. M., Hemmer, B. M., Khan, R., Liu, Y., Huang, M., Zhu, J. D., Castellano, J. M., Cai, D., Marcora, E., et al. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105615 · Cited by 73
“8 million by 2050, thus representing an urgent public health crisis (Alzheimer's Association, 2021; Hebert et al. 2013).”
BackgroundInfluentialWalker, D. G., Lue, L. F., Paul, G., Patel, A., & Sabbagh, M. N. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1001490 · Cited by 78
Matías‐Guiu, J. A., de Bobadilla, R. F., Escudero, G., Pérez‐Pérez, J., Cortés, A., Morenas‐Rodríguez, E., Valles‐Salgado, M., Moreno‐Ramos, T., Kulisevsky, J., & Matías‐Guiu, J. (2014) · Neurología · doi:10.1016/j.nrl.2014.05.004 · Cited by 77
Grant, W. B. (2016) · Journal of the American College of Nutrition · doi:10.1080/07315724.2016.1161566 · Cited by 79
Austin, S. A., & Katušić, Z. S. (2016) · Circulation Research · doi:10.1161/circresaha.116.309686 · Cited by 73
Home-Based Video Telemedicine for Dementia Management
Moo, L. R., Gately, M., Jafri, Z., & Shirk, S. D. (2019) · Clinical Gerontologist · doi:10.1080/07317115.2019.1655510 · Cited by 77
Robert, J., Stukas, S. K., Button, E. B., Cheng, W. H., Lee, M., Fan, J., Wilkinson, A., Kulić, I., Wright, S. D., & Wellington, C. L. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.005 · Cited by 78
The effect of telemedicine on cognitive decline in patients with dementia
Kim, H. S., Jhoo, J. H., & Jang, J. (2015) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x15615049 · Cited by 75
O-GlcNAcylation as a Therapeutic Target for Alzheimer’s Disease
Park, J., Lai, M. K. P., Arumugam, T. V., & Jo, D. (2020) · NeuroMolecular Medicine · doi:10.1007/s12017-019-08584-0 · Cited by 79
Diabetes and Alzheimer’s Disease: Might Mitochondrial Dysfunction Help Deciphering the Common Path?
Potenza, M. A., Sgarra, L., Desantis, V., Nacci, C., & Montagnani, M. (2021) · Antioxidants · doi:10.3390/antiox10081257 · Cited by 78
“Because of the increasing proportion of older people in the overall human population, it is predicted that by 2050 more than 140 million people worldwide will suffer from AD [14].”
Backgroundde Vries, L. E., Huitinga, I., Kessels, H. W. H. G., Swaab, D. F., & Verhaagen, J. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00719-7 · Cited by 85
“Approximately two-thirds of patients diagnosed with AD are female [290], which also holds true after controlling for age [291].”
Johnson, L. A., Zuloaga, K. L., Kugelman, T., Mader, K. S., Morré, J. T., Zuloaga, D. G., Weber, S. J., Marzulla, T., Mulford, A., Button, D. A., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.12.008 · Cited by 74
Treatment Patterns with Antidementia Drugs in the United States: Medicare Cohort Study
Koller, D., Hua, T., & Bynum, J. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14226 · Cited by 75
Is sporadic Alzheimer′s disease a developmental disorder?
Arendt, T., Stieler, J., & Ueberham, U. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14036 · Cited by 76
Older patients are still under-represented in clinical trials of Alzheimer's disease
Banzi, R., Camaioni, P., Tettamanti, M., Bertele’, V., & Lucca, U. (2016) · Alzheimer's Research & Therapy · doi:10.1186/s13195-016-0201-2 · Cited by 74
Gorji, H. T., & Haddadnia, J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.08.013 · Cited by 77
Graff‐Radford, N. R., & Jones, D. T. (2019) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000689 · Cited by 76
Lao, P. J., Handen, B. L., Betthauser, T. J., Mihaila, I., Hartley, S. L., Cohen, A. D., Tudorascu, D., Bulova, P. D., Lopresti, B. J., Tumuluru, R. V., et al. (2017) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2017.05.001 · Cited by 75
Burke, S. L., Hu, T., Fava, N. M., Li, T., Rodriguez, M. J., Schuldiner, K. L., Burgess, A., & Laird, A. R. (2018) · Journal of Women & Aging · doi:10.1080/08952841.2018.1419476 · Cited by 77
Mediterranean diet and cognitive health
Féart, C., Samieri, C., & Barberger‐Gateau, P. (2014) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000131 · Cited by 77
Chan, C., Fage, B. A., Burton, J. K., Smailagic, N., Gill, S. S., Herrmann, N., Nikolaou, V., Quinn, T. J., Noel-Storr, A. H., & Seitz, D. P. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011414.pub2 · Cited by 71
Roalf, D. R., Moore, T. M., Wolk, D. A., Arnold, S. E., Mechanic-Hamilton, D. J., Rick, J. H., Kabadi, S., Ruparel, K., Chen‐Plotkin, A. S., Chahine, L. M., et al. (2016) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-312723 · Cited by 74
Formaldehyde, Epigenetics, and Alzheimer’s Disease
Wang, F., Chen, D., Wu, P., Klein, C. B., & Jin, C. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00090 · Cited by 74
Breath-based non-invasive diagnosis of Alzheimer’s disease: a pilot study
Tiele, A., Wicaksono, A. N., Daulton, E., Ifeachor, E., Eyre, V., Clarke, S., Timings, L., Pearson, S., Covington, J. A., & Li, X. (2019) · Journal of Breath Research · doi:10.1088/1752-7163/ab6016 · Cited by 73
Mattke, S., Cho, S. K., Bittner, T., Hlávka, J. P., & Hanson, M. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12081 · Cited by 73
Commonalities between Copper Neurotoxicity and Alzheimer’s Disease
Patel, R., & Aschner, M. (2021) · Toxics · doi:10.3390/toxics9010004 · Cited by 73
New Therapeutic Approaches for Alzheimer’s Disease and Cerebral Amyloid Angiopathy
Saitô, S., & Ihara, M. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00290 · Cited by 77
Understanding the cause of sporadic Alzheimer’s disease
Zetterberg, H., & Mattsson, N. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.915740 · Cited by 73
Caselli, R. J., Beach, T. G., Knopman, D. S., & Graff-Radford, N. R. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.02.011 · Cited by 81
Sex, Race, and Age Differences in Prevalence of Dementia in Medicare Claims and Survey Data
Zhu, Y., Chen, Y., Crimmins, E. M., & Zissimopoulos, J. (2020) · The Journals of Gerontology Series B · doi:10.1093/geronb/gbaa083 · Cited by 72
Wu, H., Qiu, W., Zhu, X., Li, X., Xie, Z., Carreras, I., Dedeoglu, A., Dyke, T. E. V., Han, Y. W., Karimbux, N. Y., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.912709 · Cited by 73
Cellular senescence in brain aging and cognitive decline
Shafqat, A., Khan, S., Omer, M. H., Niaz, M., Albalkhi, I., AlKattan, K. M., Yaqinuddin, A., Tchkonia, T., Kirkland, J. L., & Hashmi, S. K. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1281581 · Cited by 81
Metadata
- Authors
- Hebert, L. E., Weuve, J., Scherr, P. A., & Evans, D. A.
- Affiliations
- Rush University (US)
- Venue
- Neurology
- Published
- 2013-05-07
- Volume
- 80
- Issue
- 19
- Pages
- 1778-1783
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC3719424
- OpenAlex
- W2071068165
- Cited by
- 2,642
- References
- 19
- Citations by year
- 2026: 81 · 2025: 119 · 2024: 192 · 2023: 167 · 2022: 242 · 2021: 312 · 2020: 317 · 2019: 232 · 2018: 210 · 2017: 212 · 2016: 217 · 2015: 160 · 2014: 129 · 2013: 47
- FWCI
- 131.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Neurology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Alzheimer's Association
- National Institutes of Health (AG011101)
- National Institute on Aging (RC2AG036650, U01AG012505, R01AG030146, AG011101, R01AG011101, P30AG010161, R01AG021972, R01AG009966)
- National Heart, Lung, and Blood Institute (R01HL084209)
- National Institute of Nursing Research (R01NR009543, R01NR010211)
- National Institute of Environmental Health Sciences (R21ES020404, R01ES010902, R21ES019712)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Social Sciences › Demography › Insurance, Mortality, Demography, Risk Management
- Keywords
- Alzheimer's disease, dementia prevalence, population projections, older adults, age-specific prevalence, racial differences, educational attainment, population aging, United States
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Female, Forecasting, Humans, Longitudinal Studies, Male, Population Surveillance, United States, Incidence, Censuses
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
